Business Weekly - Cambridge, UK

Abcam's shares were up over 5 per cent to 316 p on news that its profits would be ten per cent higher than previously forecast. Cambridge based Abcam markets antibodies via its own online catalogue. A trading update ahead of its results for the year ended June 30 reported: “Sales in the second half have continued their strong growth trend with the result that the company expects full-year sales to slightly exceed market expectations. Due to the stronger sales, together with slightly lower expenses, pre-tax profits will exceed market expectations by about 10 per cent.